February 23, 2017
People with Gaucher disease and those with Parkinson's disease (PD) can share a common link: mutations in the GBA gene. Identifying and evaluating people who carry a GBA mutation, whether they have Gaucher or PD or are related to someone living with one of these diseases, is vital to helping scientists learn more and develop improved treatments.
The Parkinson's Progression Markers Initiative (PPMI) is a landmark clinical study sponsored by The Michael J. Fox Foundation to better understand the progression of and risk factors for Parkinson's disease.
People who have been genetically tested, as well as those who have not, may be eligible to participate.
Autosomal recessive juvenile Parkinson disease
Gaucher disease perinatal lethal
Gaucher disease type 1
Gaucher disease type 2
Gaucher disease type 3
- Not a rare disease
Parkinson disease type 3